Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study

Domaine:

healthcare
Créateur:
VanSimVinKim
Éditeur:
Eur
Hôte:
Background Multiple host blood transcriptional signatures have been developed as non-sputum triage tests for tuberculosis (TB). We aimed to compare the diagnostic performance of 20 blood transcriptomic TB signatures for differentiating between symptomatic patients who have TB versus other respiratory diseases (ORD). Methods As part of a nested case–control study, individuals presenting with respiratory symptoms at primary healthcare clinics in Ethiopia, Malawi, Namibia, Uganda, South Africa and The Gambia were enrolled. TB was diagnosed based on clinical, microbiological and radiological findings. Transcriptomic signatures were measured in whole blood using microfluidic real-time quantitative PCR. Diagnostic performance was benchmarked against the World Health Organization Target Product Profile (TPP) for a non-sputum TB triage test. Results Among 579 participants, 158 had definite, microbiologically confirmed TB, 32 had probable TB, while 389 participants had ORD. Nine signatures differentiated between ORD and TB with equivalent performance (Satproedprai7: area under the curve 0.83 (95% CI 0.79–0.87); Jacobsen3: 0.83 (95% CI 0.79–0.86); Suliman2: 0.82 (95% CI 0.78–0.86); Roe1: 0.82 (95% CI 0.78–0.86); Kaforou22: 0.82 (95% CI 0.78–0.86); Sambarey10: 0.81 (95% CI 0.77–0.85); Duffy9: 0.81 (95% CI 0.76–0.86); Gliddon3: 0.8 (95% CI 0.75–0.85); Suliman4 0.79 (95% CI 0.75–0.84)). Benchmarked against a 90% sensitivity, these signatures achieved specificities between 44% (95% CI 38–49%) and 54% (95% CI 49–59%), not meeting the TPP criteria. Signature scores significantly varied by HIV status and country. In country-specific analyses, several signatures, such as Satproedprai7 and Penn-Nicholson6, met the minimal TPP criteria for a triage test in Ethiopia, Malawi and South Africa. Conclusion No signatures met the TPP criteria in a pooled analysis of all countries, but several signatures met the minimum criteria for a non-sputum TB triage test in some countries.

Visit

doi.org

Licenses

http://creativecommons.org/licenses/by-nc/4.0/

Similaires

Blood transcriptomic signatures for symptomatic TB in an African multi-cohort study: Public, subject-level signature scores, RT-qPCR data, and metadataMulticohort assessment of plasma metabolic signatures of tuberculosis disease in childrenBlood transcriptomic signatures in children with tuberculosis in a treatment-shortening trial: Public, subject-level signature scores, RT-qPCR data, and metadataData_Sheet_1_Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.ZIPData_Sheet_2_Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.ZIPData_Sheet_3_Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.docx

Blood transcriptomic signatures for symptomatic TB in an African multi-cohort study: Public, subject-level signature scores, RT-qPCR data, and metadata

Here we provide the public, subject-level datasets containing key variables necessary t

Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children

Abstract Current microbiological tests for tuberculosis (TB) disease in children h

Blood transcriptomic signatures in children with tuberculosis in a treatment-shortening trial: Public, subject-level signature scores, RT-qPCR data, and metadata

The SHINE trial demonstrated that 4 months of treatment was non-inferior to 6 months for children wi

Data_Sheet_1_Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.ZIP

Recently, host whole blood gene expression signatures have been identified for diagnosis of tuber

Data_Sheet_2_Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.ZIP

Recently, host whole blood gene expression signatures have been identified for diagnosis of tuber

Data_Sheet_3_Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification.docx

Recently, host whole blood gene expression signatures have been identified for diagnosis of tuber